Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Paul A. Grayson currently holds 75,000 shares of Skye Bioscience, Inc. (SKYE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul A. Grayson has been a net neutral trader of SKYE stock. They have purchased $0 and sold $0 worth of shares.
Paul A. Grayson's most recent insider trade was on Mar 31, 2026, when they sold 75,000 shares at $0.00 per share.
Paul A. Grayson serves as Executive at Skye Bioscience, Inc. (SKYE). They have executed 7 insider transactions totaling $0 over their tenure at the company.
Paul A. Grayson holds the position of Executive at Skye Bioscience, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Paul A. Grayson has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Paul A. Grayson was on Mar 31, 2026, when they purchased $0 worth of SKYE shares. This transaction involved 75,000 shares at N/A per share.
Paul A. Grayson currently owns 75,000 shares of Skye Bioscience, Inc. (SKYE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Paul A. Grayson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Paul A. Grayson has 7 Form 4 filings on record as an insider at Skye Bioscience, Inc..
Set alerts for Paul A. Grayson and 40,000+ other insiders.